Medical Associates Clinic PC, Dubuque, Iowa (5 participants): Michael H. Scott, MD (I); Shannon R. Walsh, COA (C); Brenda L. Tebon, COT (P); Marcia J. Moyle, COT (P). Retina and Vitreous Associates of Kentucky, Lexington, Kentucky (5 participants): Thomas W. Stone, MD (I); ...
Findings In this post hoc analysis of a clinical trial, persistent diabetic macular edema through 24 weeks was less likely with 2.0-mg aflibercept or 0.3-mg ranibizumab than 1.25-mg bevacizumab, and among eyes with persistent DME through 24 weeks, chronic persistent diabetic macular edema through ...